PPM1A
Protein phosphatase 1A
Also known as: MGC9201, PP2CA, PP2Calpha, PPM1A_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P35813
- Gene
- PPM1A
- Ensembl
- ENSG00000100614
- Chromosome
- 14
- Canonical length
- 382 aa
- Protein class
- Enzymes, Predicted intracellular proteins
- Subcellular location
- Plasma membrane,Cytosol
OverviewNCBI Gene
The protein encoded by this gene is a member of the PP2C family of Ser/Thr protein phosphatases. PP2C family members are known to be negative regulators of cell stress response pathways. This phosphatase dephosphorylates, and negatively regulates the activities of, MAP kinases and MAP kinase kinases. It has been shown to inhibit the activation of p38 and JNK kinase cascades induced by environmental stresses. This phosphatase can also dephosphorylate cyclin-dependent kinases, and thus may be involved in cell cycle control. Overexpression of this phosphatase is reported to activate the expression of the tumor suppressor gene TP53/p53, which leads to G2/M cell cycle arrest and apoptosis. Three alternatively spliced transcript variants encoding distinct isoforms have been described. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
382 residues, UniProt reviewed canonical sequence.
>P35813|PPM1A
1 MGAFLDKPKM EKHNAQGQGN GLRYGLSSMQ GWRVEMEDAH TAVIGLPSGL ESWSFFAVYD
61 GHAGSQVAKY CCEHLLDHIT NNQDFKGSAG APSVENVKNG IRTGFLEIDE HMRVMSEKKH
121 GADRSGSTAV GVLISPQHTY FINCGDSRGL LCRNRKVHFF TQDHKPSNPL EKERIQNAGG
181 SVMIQRVNGS LAVSRALGDF DYKCVHGKGP TEQLVSPEPE VHDIERSEED DQFIILACDG
241 IWDVMGNEEL CDFVRSRLEV TDDLEKVCNE VVDTCLYKGS RDNMSVILIC FPNAPKVSPE
301 AVKKEAELDK YLECRVEEII KKQGEGVPDL VHVMRTLASE NIPSLPPGGE LASKRNVIEA
361 VYNRLNPYKN DDTDSTSTDD MWLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PPM1A can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.26
- Highest tissue expression
- 135 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 135 nTPM
- skeletal muscle: 74 nTPM
- tongue: 71 nTPM
- testis: 51 nTPM
- liver: 48 nTPM
- retina: 47 nTPM
Single-cell type
- late spermatids: 999 nCPM
- early spermatids: 534 nCPM
- neutrophils: 414 nCPM
- platelets: 410 nCPM
- late primary spermatocytes: 271 nCPM
- neutrophil progenitors: 230 nCPM
Immune cell
- basophil: 5.4 nTPM
- neutrophil: 4.4 nTPM
- eosinophil: 3 nTPM
- naive B-cell: 3 nTPM
- NK-cell: 2.9 nTPM
- T-reg: 2.6 nTPM
Brain region
- cerebellum: 100 nTPM
- hypothalamus: 96 nTPM
- white matter: 91 nTPM
- cerebral cortex: 89 nTPM
- pons: 86 nTPM
- medulla oblongata: 79 nTPM
ReferencesPubMed · IEDB
Publications for PPM1A from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
3 publications
- Role of protein phosphatase magnesium-dependent 1A and anti-protein phosphatase magnesium-dependent 1A autoantibodies in ankylosing spondylitis.
2014 · Arthritis Rheumatol · RCR 0.9 · 29 citations - Autoantibodies against Protein Phosphatase Magnesium-Dependent 1A as a Biomarker for Predicting Radiographic Progression in Ankylosing Spondylitis Treated with Anti-Tumor Necrosis Factor Agents.
2020 · J Clin Med · RCR 0.6 · 9 citations - Anti-protein phosphatase magnesium-dependent 1A-IgM levels in patients with active ankylosing spondylitis: a potential biomarker.
2024 · Adv Rheumatol · RCR 0.2 · 1 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.16
- gnomAD pLI
- 1
- gnomAD missense Z
- 2.58
- DepMap mean gene effect
- 0.06
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cellular response to transforming growth factor beta stimulus
- N-terminal protein myristoylation
- negative regulation of BMP signaling pathway
- negative regulation of canonical NF-kappaB signal transduction
- negative regulation of non-canonical NF-kappaB signal transduction
- negative regulation of transcription by RNA polymerase II
- negative regulation of transforming growth factor beta receptor signaling pathway
- positive regulation of canonical NF-kappaB signal transduction
- positive regulation of canonical Wnt signaling pathway
- positive regulation of DNA-templated transcription
- positive regulation of protein export from nucleus
- protein dephosphorylation
- protein export from nucleus
- regulation of canonical NF-kappaB signal transduction
- regulation of cell cycle
Molecular functions
- calmodulin-dependent protein phosphatase activity
- magnesium ion binding
- manganese ion binding
- protein serine/threonine phosphatase activity
- R-SMAD binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- PPM-type phosphatase, divalent cation binding
- PPM-type phosphatase-like domain
- Protein serine/threonine phosphatase 2C, C-terminal
- Protein phosphatase 2C
- PPM-type phosphatase-like domain superfamily
- Phosphatase 2C, C-terminal domain superfamily
- Protein phosphatase 2C
- Protein serine/threonine phosphatase 2C, C-terminal domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PPM1A in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PPM1A as an antibody target. Whether an autoantibody or antibody against PPM1A could matter depends on whether native PPM1A is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PPM1A is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PPM1A as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...